 Adverse effect therapeutic vasoconstrictors experimental acute pancreatitis Alpha-adrenergic drugs hypotension severe acute pancreatitis systemic arterial pressure phenylephrine pancreatic microcirculatory perfusion inadequate tissue perfusion critical progression edematous pancreatitis parenchymal necrosis vasoconstrictors harmful pancreatitis effect phenylephrine cerulein-induced mild pancreatitis Sprague-Dawley rats experimental groups following infusion regimens cerulein cae phenylephrine phe cae saline NS NS phe cae phenoxybenzamine pbz phe NS pbz phe NS Initial terminal hematocrit serum amylase activity blood ionized calcium concentration animals hours infusion Macroscopic histologic changes pathologist Phenylephrine severity cerulein-induced pancreatitis significant adverse changes serum amylase hematocrit ionized calcium peripancreatitic soap formation cell vacuolization changes alpha-adrenergic receptor blockade phenoxybenzamine phenylephrine deleterious acute experimental pancreatitis first demonstration effect pharmacologic vasoconstrictor microcirculatory changes important transition mild pancreatitis Caution use vasoconstrictor drugs patients acute pancreatitis